Evidence map›Paper›PMID 27893926›Full record

ArticleBiometrics2017

Estimation of the optimal regime in treatment of prostate cancer recurrence from observational data using flexible weighting models.

Jincheng Shen, Lu Wang, Jeremy M G Taylor

Abstract read
In one paragraph

Article in Biometrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Estimating the causal effects of multiple intermittent treatments with application to COVID-19.Journal of the Royal Statistical Society. Series C, Applied statistics · 2023
    Article
  3. Article
  4. Ranking tailoring variables for constructing individualized treatment rules: an application to schizophrenia.Journal of the Royal Statistical Society. Series C, Applied statistics · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A Framework for Treatment Decision Making at Prostate Cancer Recurrence.Medical decision making : an international journal of the Society for Medical Decision Making · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jincheng ShenDepartment of Biostatistics, Harvard School of Public Health, 02115, Boston, Massachusetts, USA.
Lu WangDepartment of Biostatistics, University of Michigan, 48109, Ann Arbor, Michigan, USA.
Jeremy M G TaylorDepartment of Biostatistics, University of Michigan, 48109, Ann Arbor, Michigan, USA.

Funding

Modeling to Improve Prostate Cancer Outcomes Across Diverse PopulationsU01CA199338 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DE KONING, HARRY J, ETZIONI, RUTH D · 2015 to 2019
$5.2M
Statistical Methods for Cancer BiomarkersR01CA129102 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GHOSH, DEBASHIS, TAYLOR, JEREMY M.G. · 2009 to 2021
$3.3M
NCI NIH HHS R01 CA129102NCI NIH HHS U01 CA199338
6 · The paper itself

Abstract

Prostate cancer patients are closely followed after the initial therapy and salvage treatment may be prescribed to prevent or delay cancer recurrence. The salvage treatment decision is usually made dynamically based on the patient's evolving history of disease status and other time-dependent clinical covariates. A multi-center prostate cancer observational study has provided us data on longitudinal prostate specific antigen (PSA) measurements, time-varying salvage treatment, and cancer recurrence time. These data enable us to estimate the best dynamic regime of salvage treatment, while accounting for the complicated confounding of time-varying covariates present in the data. A Random Forest based method is used to model the probability of regime adherence and inverse probability weights are used to account for the complexity of selection bias in regime adherence. The optimal regime is then identified by the largest restricted mean survival time. We conduct simulation studies with different PSA trends to mimic both simple and complex regime adherence mechanisms. The proposed method can efficiently accommodate complex and possibly unknown adherence mechanisms, and it is robust to cases where the proportional hazards assumption is violated. We apply the method to data collected from the observational study and estimate the best salvage treatment regime in managing the risk of prostate cancer recurrence.

Indexed as

Prostatic NeoplasmsHumansMaleNeoplasm Recurrence, LocalProstate-Specific AntigenSalvage TherapyProstate-Specific AntigenCausal inferenceDynamic treatment regimeInverse probability weightingRandom forestRestricted mean survival time

Identifiers

PMID27893926
PMCPMC5466876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.